MENLO PARK, Calif., May 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...
Morning Overview on MSN
A single blood test that screens for many cancers could reach patients soon
Two large-scale clinical trials are generating the strongest evidence yet on whether a single blood draw can detect dozens of ...
Good day, ladies and gentlemen, and welcome to today's GRAIL analyst call. [Operator Instructions] Please be advised that this conference call is being recorded. GRAIL Investor Relations. Please begin ...
The PATHFINDER 2 study evaluated the safety and performance of the Galleri ® multi-cancer early detection (MCED) test when used alongside standard-of-care cancer screenings in the U.S. and Canada. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results